PCSK9 and diabetes mellitus: Additionally, considering that PCSK9 promotes the clearance of oxidized LDL, subsequently increasing the synthesis of LDL receptors, the use of PCSK9 inhibitors can lower LDL concentrations in patients with diabetes (Chen et al., 2023).